These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17050357)

  • 21. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary cavitation lesions in patients infected with the human immunodeficiency virus: an analysis of a series of 78 cases].
    Rodríguez Arrondo F; von Wichmann MA; Arrizabalaga J; Iribarren JA; Garmendia G; Idígoras P
    Med Clin (Barc); 1998 Dec; 111(19):725-30. PubMed ID: 9922954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
    Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
    Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
    Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spectrum of diseases in patients hospitalized with HIV infection in the HAART era].
    Valencia ME; Martín-Carbonero L; López M; Soriano V; Moreno V; González Lahoz J
    Med Clin (Barc); 2002 Sep; 119(8):293-5. PubMed ID: 12236969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
    de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
    Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.
    Fokouo JV; Vokwely JE; Noubiap JJ; Nouthe BE; Zafack J; Minka Ngom ES; Dalil AB; Ngo Nyeki AR; Bengono G; Njock R
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):436-41. PubMed ID: 25741887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HAART slows progression to anal cancer in HIV-infected MSM.
    Duncan KC; Chan KJ; Chiu CG; Montaner JS; Coldman AJ; Cescon A; Au-Yeung CG; Wiseman SM; Hogg RS; Press NM
    AIDS; 2015 Jan; 29(3):305-11. PubMed ID: 25686679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
    Pantanowitz L; Bohac G; Cooley TP; Aboulafia D; Dezube BJ
    BJU Int; 2008 Jun; 101(12):1519-23. PubMed ID: 18384640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease.
    Baron AD; Hollander H
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):992-6. PubMed ID: 8214956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.
    Aramaki M; Silachamroon U; Desakorn V; Maek-A-nantawat W; Waiwaruwut J; Jutiwarakun K; Kim JH; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):138-45. PubMed ID: 20578492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
    Núñez M; Asencio R; Valencia ME; Leal M; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2003 May; 19(5):363-8. PubMed ID: 12803995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.